Stock Research for EPZM

EPZM
Current Price

$17.5750


Latest Update: 2018-02-23 16:00:00

High
$ 17.6500
Low
$ 17.5500
Close
$ 17.6000
Volume
30463
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

EPZM Stock Chart & Research Data

The EPZM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EPZM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EPZM Due diligence Resources & Stock Charts

The EPZM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EPZM Detailed Price Forecast - CNN Money CNN View EPZM Detailed Summary - Google Finance
Yahoo View EPZM Detailed Summary - Yahoo! Finance Zacks View EPZM Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View EPZM Trends & Analysis - Trade-Ideas Barrons View EPZM Major Holders - Barrons
NASDAQ View EPZM Call Transcripts - NASDAQ Seeking View EPZM Breaking News & Analysis - Seeking Alpha
Spotlight View EPZM Annual Report - CompanySpotlight.com OTC Report View EPZM OTC Short Report - OTCShortReport.com
TradeKing View EPZM Fundamentals - TradeKing Charts View EPZM SEC Filings - Bar Chart
WSJ View Historical Prices for EPZM - The WSJ Morningstar View Performance/Total Return for EPZM - Morningstar
MarketWatch View the Analyst Estimates for EPZM - MarketWatch CNBC View the Earnings History for EPZM - CNBC
StockMarketWatch View the EPZM Earnings - StockMarketWatch MacroAxis View EPZM Buy or Sell Recommendations - MacroAxis
Bullish View the EPZM Bullish Patterns - American Bulls Short Pains View EPZM Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View EPZM Stock Mentions - StockTwits PennyStocks View EPZM Stock Mentions - PennyStockTweets
Twitter View EPZM Stock Mentions - Twitter Invest Hub View EPZM Investment Forum News - Investor Hub
Yahoo View EPZM Stock Mentions - Yahoo! Message Board Seeking Alpha View EPZM Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for EPZM - SECform4.com Insider Cow View Insider Transactions for EPZM - Insider Cow
CNBC View EPZM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EPZM - OTC Markets
Yahoo View Insider Transactions for EPZM - Yahoo! Finance NASDAQ View Institutional Holdings for EPZM - NASDAQ


Stock Charts

FinViz View EPZM Stock Insight & Charts - FinViz.com StockCharts View EPZM Investment Charts - StockCharts.com
BarChart View EPZM Stock Overview & Charts - BarChart Trading View View EPZM User Generated Charts - Trading View


Latest Financial News for EPZM

Epizyme to Participate in Leerink Partners 7th Annual Global Healthcare Conference
Posted on Wednesday February 07, 2018

CAMBRIDGE, Mass., Feb. 07, 2018-- Epizyme, Inc., a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will participate in a fireside chat at the ...


ICYMI: Epizyme, MoviePass, And A Bull Call On Novavax
Posted on Wednesday January 10, 2018

In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 10, 2018. Novavax Back In Favor Shares of Novavax, Inc (NASDAQ: NVAX ) got a heavy dose of upside when a bullish analyst ...


Morgan Stanley: Epizyme Has 'Blockbuster' Cancer Drug In The Making
Posted on Wednesday January 10, 2018

Clinical-stage biopharma company Epizyme Inc (NASDAQ: EPZM )'s tazemetostat has shown effectiveness in treating blood cancers and solid tumors with minimal toxicities in early- and mid-stage trials, according ...


Does Epizyme Inc’s (NASDAQ:EPZM) Past Performance Indicate A Weaker Future?
Posted on Tuesday December 26, 2017

Examining Epizyme Inc’s (NASDAQ:EPZM) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations, which isRead More...


$-0.56 EPS Expected for Epizyme, Inc. (EPZM)
BZ Weekly - 1 hour ago
Qs Investors Ltd, a New York-based fund reported 92,668 shares. Voya Mngmt Limited Liability Company, a Georgia-based fund reported 605,089 shares.
Epizyme (NASDAQ:EPZM) Earns Media Impact Score of 0.11 - The Ledger Gazette
ValuEngine Upgrades Epizyme (NASDAQ:EPZM) to “Hold” - The Lincolnian Online

Epizyme Inc Forecasted to Post Q1 2018 Earnings of ($0.62) Per Share (EPZM)
The Ledger Gazette - 16 hours ago
Epizyme Inc (NASDAQ:EPZM) - Research analysts at Leerink Swann issued their Q1 2018 EPS estimates for Epizyme in a report issued on Monday, Zacks Investment Research reports.
Analysts See $-0.56 EPS for Epizyme, Inc. (EPZM); Fairpointe Capital Has Cut ... - MoneyMakingArticles
Epizyme (NASDAQ:EPZM) Rating Increased to Buy at BidaskClub - The Lincolnian Online

Epizyme, Inc. (EPZM) EPS Estimated At $-0.56
Reurope - Feb 22, 2018
Ubs Asset Mngmt Americas stated it has 0% in Epizyme, Inc. (NASDAQ:EPZM). Bank Of America Corporation De invested in 0% or 27,794 shares.
Analysts See $-0.56 EPS for Epizyme, Inc. (EPZM) - KL Daily
EPS for Epizyme, Inc. (EPZM) Expected At $-0.56 - BZ Weekly

Short-term Option Swing Trade Ahead of Earnings in Epizyme Inc
CML News - Feb 16, 2018
The results here are provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation.

Enter a stock symbol to view the stock details.